Finance

Lists
Why is AURA down 2,15%?
Dive Deeper
AURA:NASDAQ
Aura Biosciences Inc
6,14 US$
-2,15%
(-0,13) 1D
14 ოქტ, 11:09:25 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
6,21 US$
High
6,28 US$
Low
6,10 US$
Mkt. cap
636,23 მლნ.
Avg. vol.
945,73 ათ.
Volume
224,71 ათ.
52-wk high
9,54 US$
52-wk low
4,73 US$
EPS
-1,76 US$
Beta
0,41
Shares outstanding
103,70 მლნ.
No. of employees
113
Open
6,21 US$
High
6,28 US$
Low
6,10 US$
Mkt. cap
636,23 მლნ.
Avg. vol.
945,73 ათ.
Volume
224,71 ათ.
52-wk high
9,54 US$
52-wk low
4,73 US$
EPS
-1,76 US$
Beta
0,41
Shares outstanding
103,70 მლნ.
No. of employees
113
News stories
From web sources and news partners
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
Headquartersბოსტონი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteaurabiosciences.com
Analyst ratings
Based on 2 analysts giving stock ratings to AURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current 6,14 US$
23,00 US$ (+274,90%)
Average
20,50 US$ (+234,15%)
Lowest
18,00 US$ (+193,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Oliver McCammon
LifeSci Capital
Buy
Maintained
23,00 US$
+274,9%
08/12/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
18,00 US$
+193,4%
08/12/2026
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
15,00 US$
+144,5%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22,18 მლნ.
21,90 მლნ.
27,96 მლნ.
30,75 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,73 მლნ.
5,34 მლნ.
6,91 მლნ.
17,32 მლნ.
Operating expense
27,91 მლნ.
27,24 მლნ.
34,87 მლნ.
48,07 მლნ.
Total operating expenses
27,91 მლნ.
27,24 მლნ.
34,87 მლნ.
48,07 მლნ.
Operating income
-27,91 მლნ.
-27,24 მლნ.
-34,87 მლნ.
-48,07 მლნ.
Other non operating income
-13,00 ათ.
149,00 ათ.
2,00 ათ.
154,00 ათ.
EBT including unusual items
-26,10 მლნ.
-25,54 მლნ.
-33,67 მლნ.
-45,61 მლნ.
EBT excluding unusual items
-26,10 მლნ.
-25,54 მლნ.
-33,67 მლნ.
-45,61 მლნ.
Income tax expense
26,00 ათ.
15,00 ათ.
11,00 ათ.
29,00 ათ.
Effective tax rate
-0,10%
-0,06%
-0,03%
-0,06%
Other operating expenses
-
-
-
-
Net income
-26,13 მლნ.
-25,56 მლნ.
-33,68 მლნ.
-45,64 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1,82 მლნ.
1,54 მლნ.
1,19 მლნ.
2,31 მლნ.
Interest expense
-
-
-
-
Net interest expenses
1,82 მლნ.
1,54 მლნ.
1,19 მლნ.
2,31 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,63 მლნ.
-26,96 მლნ.
-34,59 მლნ.
-47,81 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები